MEDBOT-B(02252): The Stock Exchange approves the listing of the company's H-shares for full circulation.

21:35 13/02/2026

Weicai Robotics-B (02252) announced that the company has received approval from the Hong Kong Stock Exchange on February 13, 2026 to list and trade 5,989,800 H shares (convertible H shares) (the total number of non-listed shares that are about to be converted and listed). The conversion and listing will involve a total of 5,989,800 non-listed shares held by two shareholders of the company (participating shareholders), representing approximately 0.5808% of the total number of shares issued by the company as of the date of this announcement.

MEDBOT-B (02252) Announcement: The company has received approval from the Hong Kong Stock Exchange on February 13, 2026 for the listing and trading of 5.98 million H shares (convertible H shares) (the total number of non-listed shares to be converted and listed). The conversion and listing will involve a total of 5.98 million non-listed shares held by two shareholders (participating shareholders) of the company, representing approximately 0.5808% of the total issued shares of the company as of the date of this announcement.

ZHIDA TECH (02650) has been included in the Hang Seng Composite Index and is expected to enter the Hong Kong Stock Connect on March 9th.

MP CARDIOFLOW-B(02160): Implantable cardiac resynchronization defibrillator entering Innovative Medical Management special review process.

NUR HOLDINGS (00254) issues profit warning, expected that the company's owners' share of the mid-term losses will increase by approximately HK$22 million to HK$25 million compared to the same period last year.

ZHIDA TECH (02650) has been included in the Hang Seng Composite Index and is expected to enter the Hong Kong Stock Connect on March 9th.

MP CARDIOFLOW-B(02160): Implantable cardiac resynchronization defibrillator entering Innovative Medical Management special review process.